VCYT
Veracyte, Inc.
NASDAQ · Healthcare · Biotechnology · US
$42.53
−4.79%Forward multiples
Based on analyst estimates
- P/E forward
- 23.70x
- P/E 2026E
- 22.43x
- P/E 2027E
- 21.96x
- P/E 2028E
- 20.74x
- P/S forward
- 5.50x
Trailing multiples
Trailing twelve months
- P/E TTM
- 29.53x
- PEG TTM
- 1.21x
- Price / book
- 2.46x
- Price / sales
- 6.08x
- Price / cash flow
- 19.17x
Enterprise value
- Enterprise value
- $3.0B
- EV / sales
- 5.29x
- EV / EBITDA
- 22.92x
- EV / EBIT
- 31.07x
- Market cap
- $3.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026